Haw Par Corporation Limited is a multinational drug manufacturing company headquartered in Singapore. It operates across multiple segments, with the Healthcare segment serving as the primary revenue generator through the production and distribution of topical analgesic products under the well-known Tiger Balm and Kwan Loong brands. These products cater to consumer needs for pain relief and are distributed widely, particularly in ASEAN and other Asian countries. The company also maintains an Investments segment for managing its portfolio, a Property segment handling real estate activities, and a Leisure segment focused on entertainment and tourism-related operations. Haw Par Corporation Limited plays a role in the healthcare and consumer goods markets by providing accessible over-the-counter remedies, while its diversified segments contribute to stability in the broader financial landscape. Founded in Singapore, it continues to emphasize its core healthcare offerings alongside complementary business lines.
Markedsdata leveret af TwelveData og Morningstar